Skip to main content
user-generated· Economics

Will the average out-of-pocket cost for Zepbound for CVS Caremark mem…

Market overview

While coverage is restored, the actual cost to patients remains a key factor in access. This question examines whether increased coverage and potential competition will lead to a tangible reduction in patient costs for Zepbound. The resolution will be based on publicly available data or CVS Caremark's official statements regarding average patient costs.

Economics prediction market

Implied probability (Yes)
40%
Closes
2029-08-26

More Economics markets

Browse all Economics markets →

Loading…